Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217431 · ClinicalTrials.gov registry record
Access BNP Clinical Performance Evaluation: Testing and Clinical Concordance Study
A clinical trial, sponsored by Beckman Coulter.
- Completed
- Registry status
- 1,361
- Enrollment target
NCT07217431: Completed study, sponsored by Beckman Coulter.
NCT07217431 is a clinical trial that has completed, run by Beckman Coulter. The registered enrollment target is 1,361 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07217431 has completed, sponsored by Beckman Coulter.
- COMPLETED
- Registry status
- 1,361 participants
- Enrollment target
Study Summary
The goal is to establish clinical performance of a BNP assay on the intended use population and establish clinical concordance on a separate device.
Primary Outcome
Subjects with BNP value above clinical decision point
Interventions
- DIAGNOSTIC_TEST BNP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,361 participants |
| Start Date | 2024-10-10 |
| Est. Completion | 2025-03-25 |
What the finished NCT07217431 record still lists
NCT07217431 is an observational study that tracks outcomes without assigning an intervention. Its 1,361 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which BNP is the first listed.
NCT07217431 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07217431 about?
NCT07217431 is a clinical study titled "Access BNP Clinical Performance Evaluation: Testing and Clinical Concordance Study". The goal is to establish clinical performance of a BNP assay on the intended use population and establish clinical concordance on a separate device.
What is the current status of trial NCT07217431?
This trial is currently completed. The enrollment target is 1,361 participants. The study started on 2024-10-10. Estimated completion is 2025-03-25.
What interventions are being tested in trial NCT07217431?
The interventions under investigation include: BNP (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07217431?
This trial is sponsored by Beckman Coulter, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05245227 · 1,358 participants · Phase 3
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
- NCT02677064 · 1,365 participants
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
- NCT04489238 · 1,366 participants
Collection of Information to Better Understand Young Onset Colorectal Cancer
- NCT07256392 · 1,370 participants · Phase 3
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI